IM Cannabis to Acquire 60% Stake in Quantum Computing Bio Data Firm
Ticker: IMCC · Form: 6-K · Filed: Oct 23, 2025 · CIK: 1792030
| Field | Detail |
|---|---|
| Company | Im Cannabis CORP. (IMCC) |
| Form Type | 6-K |
| Filed Date | Oct 23, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | mixed |
Sentiment: mixed
Topics: acquisition, term-sheet, new-venture
TL;DR
IM Cannabis is buying into quantum computing bio data, a big tech pivot.
AI Summary
IM Cannabis Corp. announced on October 23, 2025, that it has signed a non-binding term sheet to acquire a 60% stake in Innovative Quantum Computing Bio Data. This potential acquisition signifies a strategic move by IM Cannabis into the quantum computing and bio data sector.
Why It Matters
This move could diversify IM Cannabis's business beyond its traditional cannabis operations, potentially opening up new revenue streams and technological advancements.
Risk Assessment
Risk Level: medium — The acquisition is based on a non-binding term sheet, meaning the deal is not yet finalized and could fall through.
Key Numbers
- 60% — Acquisition Stake (IM Cannabis Corp. plans to acquire this percentage of Innovative Quantum Computing Bio Data.)
Key Players & Entities
- IM Cannabis Corp. (company) — Filer of the report and potential acquirer
- Innovative Quantum Computing Bio Data (company) — Target company for acquisition
- 60% (dollar_amount) — Percentage stake to be acquired
- October 23, 2025 (date) — Date of the press release and term sheet signing
FAQ
What is the nature of the business of Innovative Quantum Computing Bio Data?
The filing does not specify the exact nature of Innovative Quantum Computing Bio Data's business beyond its name suggesting involvement in quantum computing and bio data.
Is the acquisition of Innovative Quantum Computing Bio Data a binding agreement?
No, the filing states that IM Cannabis Corp. has signed a non-binding term sheet, indicating the agreement is not yet legally binding.
What is the filing date of this report?
This Form 6-K was filed on October 23, 2025.
What is the primary purpose of this Form 6-K filing?
This Form 6-K is reporting a press release dated October 23, 2025, concerning a non-binding term sheet for an acquisition.
What is IM Cannabis Corp.'s standard industrial classification?
IM Cannabis Corp.'s standard industrial classification is MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833].
Filing Stats: 165 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2025-10-23 09:29:37
Filing Documents
- zk2533877.htm (6-K) — 9KB
- exhibit_99-1.htm (EX-99.1) — 15KB
- 0001178913-25-003552.txt ( ) — 25KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit No. 99.1 Press Release dated October 23, 2025 "IM Cannabis Signs Non-Binding Term Sheet to Acquire 60% Stake in Innovative Quantum Computing Bio Data". SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IM CANNABIS CORP. (Registrant) Date: October 23, 2025 By: /s/ Oren Shuster Name: Oren Shuster Title: Chief Executive Officer and Director